Atlas FDA

SOLESTA INJECTABLE GEL

FDA premarket approval P100014/S019 · decided 2017-01-18

Approval details

PMA number
P100014
Supplement
S019
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SOLESTA INJECTABLE GEL
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2016-12-19
Decision date
2017-01-18
Days to decision
30 days
Decision code
OK30
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
Change of the internal standard used in the test method for detection of residual solvents.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26